Bliss Gvs Pharma Ltd Board of Directors
Board of Directors at Bliss GVS Pharma Ltd
Company Sec. & Compli. Officer
Managing Director
Chairman
Non-Exec. & Independent Dir.
Non-Exec. & Independent Dir.
Key Highlights
- Nandkumar Kashinath Chodankar joins the board as Chairman & Independent Directo, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Shilpa Bhatia joins the board as Independent Non Executive Women Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Shibroor N Kamath joins the board as ED / MD / CEO / Promoter, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Vijayanarayanan Mahadevan joins the board as Independent Non Exe. Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Deepak Rameshchandra Shah joins the board as Independent Non Exe. Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Bliss GVS Pharma Ltd
NSE: BLISSGVS
Share Price
Last Ten Days Market Price
| Date | |
|---|---|
| 28 Jul 2026 | 450.4 |
| 27 Jul 2026 | 461 |
| 24 Jul 2026 | 463.55 |
| 23 Jul 2026 | 462.85 |
| 22 Jul 2026 | 448.15 |
| 21 Jul 2026 | 467.25 |
| 20 Jul 2026 | 489.35 |
| 17 Jul 2026 | 482.5 |
| 16 Jul 2026 | 503.85 |
| 15 Jul 2026 | 513.65 |
Company Fundamentals for Bliss GVS Pharma Ltd
Market Cap
4,776 Cr
EPS
12.4
P/E Ratio (TTM)
36.2
P/B Ratio (TTM)
4.0
Day’s High
469.4
Day’s Low
441.7
DTE
0.0
ROE
10.8
52 Week High
552.9
52 Week Low
118.35
ROCE
16.5
Market Price of Bliss GVS Pharma Ltd
1M
1Y
3Y
5Y
Bliss GVS Pharma Ltd News Hub
Bliss GVS Pharma to table results
Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 24 October 2024. Po
Read more
18 Oct 24
Bliss GVS Pharma consolidated net profit declines 42.66% in the September 2024 quarter
Net profit of Bliss GVS Pharma declined 42.66% to Rs 24.26 crore in the quarter ended September 2024
Read more
25 Oct 24
Bliss GVS Pharma allots 1.57 lakh equity shares under ESOP
Bliss GVS Pharma has allotted 157,550 equity shares under ESOP on 04 October 2024. With this allotme
Read more
04 Oct 24
Bliss GVS Pharma schedules board meeting
Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 28 January 2025. Po
Read more
22 Jan 25
